Alar Pharmaceuticals Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was TWD 16.62 million compared to TWD 9.86 million a year ago. Basic loss per share from continuing operations was TWD 0.29 compared to TWD 0.17 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
250.5 TWD | +2.04% | 0.00% | +19.57% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.57% | 504M | |
+17.03% | 9.11B | |
-23.31% | 4.44B | |
+15.70% | 4.24B | |
+32.83% | 4.03B | |
+9.37% | 2.14B | |
+9.30% | 1.94B | |
-33.37% | 1.9B | |
-0.50% | 1.64B | |
-46.20% | 1.63B |
- Stock Market
- Equities
- 6785 Stock
- News Alar Pharmaceuticals Inc.
- Alar Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023